🔗 Share this article

Chancellor Reeves has revealed she is preparing "specific action to address cost of living issues" in next month's Budget.

During an interview with the BBC, she noted that curbing price rises is a collective task of both the government and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven developed nations this year and the following year.

Possible Utility Bill Interventions

Sources suggest the administration could intervene to reduce energy bills, for instance by cutting the present 5% rate of VAT charged on energy.

An additional option is to lower some of the policy costs currently added to household expenses.

Fiscal Constraints and Expert Predictions

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for these actions.

The view from the majority of experts is that the Chancellor will have to introduce higher taxes or budget cuts in order to fulfill her self-imposed fiscal targets.

Earlier on Thursday, analysis indicated there was a £22bn deficit for the chancellor to address, which is at the more modest range of expectations.

"It is a joint responsibility between the central bank and the government to bear down further on some of the causes of price increases," Reeves stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on likely tax increases, the chancellor said the latest data from the OBR had not altered her pledge to manifesto promises not to raise rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with rising international and trade concerns for the fiscal tax moves, likely to be focused on those "wealthiest."

International Trade Disputes

Referring to apprehensions about the UK's trade ties with China she said: "The UK's security interests invariably are paramount."

Recent declaration by Chinese authorities to increase export controls on rare earths and other resources that are key for high-technology production led American leader Donald Trump to threaten an further 100% import tax on imports from China, increasing the prospect of an full-scale commercial conflict between the two global powers.

The American finance chief labeled the Chinese decision "commercial pressure" and "a international production power grab."

Inquired about considering the US offer to join its conflict with the Asian nation, the Chancellor said she was "very concerned" by China's actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the decision was "bad for the global economy and creates additional challenges."

"It is my opinion there are fields where we need to challenge Chinese policies, but there are also valuable opportunities to trade with Chinese markets, including banking sector and other areas of the economy. We've got to maintain that balance correct."

The chancellor also affirmed she was cooperating with G7 counterparts "regarding our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

Reeves also recognized that the price the National Health Service spends on drugs could go up as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling investments in the United Kingdom, with some blaming the insufficient payments they are receiving.

Recently, the government science advisor said the cost the health service pays for drugs would need to increase to halt firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed media: "We have seen because of the cost structure, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other continental states."

"We want to ensure that patients getting care from the NHS are can receive the top life-saving treatments in the globe. And so we are looking at these issues, and... seeking to attract additional investment into Britain."